MAKO Surgical Corp. (MAKO) is a medical device company, which markets its advanced robotic arm solution, joint specific applications for the knee and hip and orthopedic implants for orthopedic procedures. The Company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specific, osteoarthritic disease. MAKOplasty is performed using the Company's RIO Robotic Arm Interactive Orthopedic system (RIO). The RIO is a technology platform that utilizes tactile guided robotic arm technology and patient specific planning and visualization to offer reproducible precision to surgeons. In October 2013, MAKO Surgical Corp. completed the acquisition of Pipeline Biomedical Holdings, Inc.'s business, which is engaged in the design, development, manufacture and commercialization of orthopedic devices and related instruments for use with both robotic devices and manual medical procedures.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Health Care Equipment & Supplies
- Sub-Industry: Health Care Equipment
- Symbol: NASDAQ:MAKO
- CUSIP: 56087910
- Web: N/A
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -107.11
- P/E Growth: N/A
Frequently Asked Questions for MAKO Surgical Corp. (NASDAQ:MAKO)
What is MAKO Surgical Corp.'s stock symbol?
MAKO Surgical Corp. trades on the NASDAQ under the ticker symbol "MAKO."
Who are some of MAKO Surgical Corp.'s key competitors?
Some companies that are related to MAKO Surgical Corp. include Partnership Assurance Group PLC (PA), GlaxoSmithKline plc (GSK), AstraZeneca plc (AZN), Merck KGaA (MKGAY), Shire PLC (SHP), Hospira (HSP), Smith & Nephew plc (SN), Omnicare (OCR), ConvaTec Group PLC (CTEC), Mediclinic International PLC (MDC), Health Net (HNT), Patheon NV (PTHN), NMC Health PLC (NMC), Catalent (CTLT), Cotiviti Holdings (COTV), Puma Biotechnology (PBYI), Hikma Pharmaceuticals Plc (HIK) and WuXi PharmaTech (Cayman) (WX).
How do I buy MAKO Surgical Corp. stock?
Shares of MAKO Surgical Corp. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is MAKO Surgical Corp.'s stock price today?
MarketBeat Community Rating for MAKO Surgical Corp. (NASDAQ MAKO)MarketBeat's community ratings are surveys of what our community members think about MAKO Surgical Corp. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of MAKO Surgical Corp. stock can currently be purchased for approximately $29.99.
Consensus Ratings for MAKO Surgical Corp. (NASDAQ:MAKO) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for MAKO Surgical Corp. (NASDAQ:MAKO)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for MAKO Surgical Corp. (NASDAQ:MAKO)Earnings History by Quarter for MAKO Surgical Corp. (NASDAQ MAKO)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|7/30/2013||Q2 2013||($0.22)||($0.42)||$28.53 million||$28.20 million||View||N/A|
|5/7/2013||Q1 2013||($0.19)||($0.21)||$24.82 million||$24.81 million||View||N/A|
|2/26/2013||Q4 2012||($0.13)||($0.13)||$30.80 million||$30.28 million||View||N/A|
|11/7/2012||Q312||($0.16)||($0.15)||$27.48 million||$29.17 million||View||N/A|
Earnings Estimates for MAKO Surgical Corp. (NASDAQ:MAKO)
Current Year EPS Consensus Estimate: $-0.81 EPS
Next Year EPS Consensus Estimate: $-0.28 EPS
Dividend History for MAKO Surgical Corp. (NASDAQ:MAKO)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for MAKO Surgical Corp. (NASDAQ:MAKO)Insider Trades by Quarter for MAKO Surgical Corp. (NASDAQ:MAKO)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|11/15/2012||William D Pruitt||Director||Buy||10,000||$13.45||$134,500.00|| |
|11/14/2012||Christopher C Dewey||Director||Buy||25,000||$13.15||$328,750.00|| |
Headline Trends for MAKO Surgical Corp. (NASDAQ:MAKO)
Latest Headlines for MAKO Surgical Corp. (NASDAQ:MAKO)
MAKO Surgical Corp. (MAKO) Chart for Sunday, July, 23, 2017